[HTML][HTML] The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

R Azziz, E Carmina, D Dewailly… - Fertility and sterility, 2009 - Elsevier
OBJECTIVE: To review all available data and recommend a definition for polycystic ovary
syndrome (PCOS) based on published peer-reviewed data, whether already in use or not, to …

Management of endocrine disease: diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency

A Nordenström, H Falhammar - European journal of …, 2019 - academic.oup.com
Non-classic congenital adrenal hyperplasia (NCAH) is a relatively common disorder
regardless of ethnicity, but most cases are never diagnosed, especially in males. A baseline …

Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline

PW Speiser, W Arlt, RJ Auchus… - The Journal of …, 2018 - academic.oup.com
Objective To update the congenital adrenal hyperplasia due to steroid 21-hydroxylase
deficiency clinical practice guideline published by the Endocrine Society in 2010 …

Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline

PW Speiser, R Azziz, LS Baskin… - The Journal of …, 2010 - academic.oup.com
Objective: We developed clinical practice guidelines for congenital adrenal hyperplasia
(CAH). Participants: The Task Force included a chair, selected by The Endocrine Society …

Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency

MG Forest - Human Reproduction Update, 2004 - academic.oup.com
Congenital adrenal hyperplasias (CAH) are inherited defects of cortisol biosynthesis. More
than 90% of CAH are caused by 21-hydroxylase deficiency (21-OHD), found in 1: 10 000 to …

Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia

C Moran, R Azziz, N Weintrob… - The Journal of …, 2006 - academic.oup.com
Context: Because many women with 21-hydroxylase (21-OH)-deficient nonclassic adrenal
hyperplasia (NCAH) carry at least one allele affected by a severe mutation of CYP21, they …

Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome

H Falhammar, A Nordenström - Endocrine, 2015 - Springer
Nonclassic congenital adrenal hyperplasia (NCAH) is one of the most frequent autosomal
recessive disorders in man with a prevalence ranging from 0.1% in Caucasians up to a few …

CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations

NMML Stikkelbroeck, LH Hoefsloot… - The Journal of …, 2003 - academic.oup.com
Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is one of the most
common autosomal recessive disorders. The aim of this study was to assess the frequencies …

Biochemical and genetic diagnosis of 21-hydroxylase deficiency

H Falhammar, A Wedell, A Nordenström - Endocrine, 2015 - Springer
Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is caused by
mutations in the CYP21A2 gene and is often fatal in its classic forms if not treated with …

The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 …

S Livadas, M Dracopoulou, A Dastamani… - Clinical …, 2015 - Wiley Online Library
Background Nonclassical congenital adrenal hyperplasia (NC‐CAH) is caused by mutations
of the CYP21A2 gene. The clinical manifestations and hormonal derangements of NC‐CAH …